Investor profile
Michael Widmann
Corporate VC & Associate Director, Portfolio Strategy & Analytics at AbbVie
Michael Widmann is an Associate Director, Portfolio Strategy & Analytics at AbbVie, whose known portfolio counts 16 companies.
Is Michael Widmann a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Associate Director, Portfolio Strategy & Analytics at AbbVie, whose known portfolio counts 16 companies
- Zag Bio
- Carisma Therapeutics
- Third Arc Bio
- Accent Therapeutics
- DISCO Pharmaceuticals
- Jnana Therapeutics
- Oisin Biotechnologies
- Soufflé Therapeutics
- Syndeio Biosciences
- Light Horse Therapeutics
- BaseLaunch
- Cephagenix
- and 4 more
Investor Profile
Michael Widmann is listed against sector Healthcare, and focus areas Biotech, Cell & Gene, Drug Discovery and Genomics in the database.
AbbVie appears in Growth, Seed and Series A rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Michael Widmann is worth approaching.
Colleagues at AbbVie
Mayara Doile
Senior Executive
São Paulo, Brazil
Wenwen He
Venture Capital
United States
Tatiana W
Investor & Partner
United States
Christine Hsieh
Venture Partner
Boston, United States
Kevin Ho
Director, Business Development & Acquisitions
San Francisco, United States
Andrew Little
Investor
Boston, United States
Doug Faunce
Executive Director
Irvine, United States
Keith Hamel
Director
Chicago, United States
Frequently asked questions
Who is Michael Widmann?
Michael Widmann is a corporate venture investor based in Chicago, Illinois, United States, listed as Associate Director, Portfolio Strategy & Analytics at AbbVie. The known portfolio of that firm counts 16 companies. That portfolio belongs to the firm, not to Michael Widmann personally.
What does Michael Widmann invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell & Gene, Drug Discovery and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Michael Widmann invest at?
AbbVie appears in Growth, Seed and Series A rounds across its known deals, and Michael Widmann is listed there as Associate Director, Portfolio Strategy & Analytics. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Michael Widmann listed at?
Michael Widmann is listed as Associate Director, Portfolio Strategy & Analytics at AbbVie. 8 other people in the database share a firm with Michael Widmann.
How do I contact Michael Widmann?
An email address, a phone number and a LinkedIn page are on file for Michael Widmann. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal